欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0490/002
药品名称Propofol 2% (20 mg/1 ml) MCT Fresenius, Emulsion zur Injektion oder Infusion
活性成分
    • Propofol 20.0 mg/ml
剂型Emulsion for injection or infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Propofol "Fresenius" 2 % mit MCT - Emulsion zur Injektion oder Infusion
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Propofol 2% MCT/LCT Fresenius
    • Latvia (LV)
      Propoven 2%, emulsion for injection or infusion
    • Lithuania (LT)
      Propoven 2% injekcinė/ infuzinė emulsija
    • Romania (RO)
    • Estonia (EE)
      PROPOVEN 2%
    • Hungary (HU)
      Propofol 2 % emulzió injekcióhoz v. infúzióhoz
    • Cyprus (CY)
      PROPOFOL 2% MCT/LCT FRESENIUS EMULSION FOR INJECTION OR INFUSION 20MG/ML
    • Czechia (CZ)
      8876/05
    • Slovakia (SK)
      Propofol 2% MCT/LCT Fresenius
    • Slovenia (SI)
许可日期2005/01/18
最近更新日期2025/08/11
药物ATC编码
    • N01AX10 propofol
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Other [Article 10.1.(a)(iii), last paragraph]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase